272 related articles for article (PubMed ID: 31437208)
1. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.
Lindgren A; Anttila M; Arponen O; Rautiainen S; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2019 Jun; 115():66-73. PubMed ID: 31084761
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
[TBL] [Abstract][Full Text] [Related]
4. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-inducible factor-1α and -2α in whole-mount prostate histology: relation with dynamic contrast-enhanced MRI and Gleason score.
Borren A; Groenendaal G; van der Groep P; Moman MR; Boeken Kruger AE; van der Heide UA; Jonges TN; van Diest PJ; van Vulpen M; Philippens ME
Oncol Rep; 2013 Jun; 29(6):2249-54. PubMed ID: 23588703
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
8. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Differentiate Between Atypical Cartilaginous Tumors and High-Grade Chondrosarcoma: Correlation With Histological Vessel Characteristics.
Jin B; Yang J; Zhen J; Xu Y; Wang C; Jing Q; Shang Y
J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):123-128. PubMed ID: 37558644
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
Liu B; Gao H; Zhou F; Zhao W; Yang Y
Clin Radiol; 2024 Jun; 79(6):e826-e833. PubMed ID: 38582634
[TBL] [Abstract][Full Text] [Related]
11. Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.
Surov A; Kim JY; Aiello M; Huang W; Yankeelov TE; Wienke A; Pech M
In Vivo; 2022; 36(1):398-408. PubMed ID: 34972741
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.
Lindgren A; Anttila M; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2023 Aug; 165():110925. PubMed ID: 37320880
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
[TBL] [Abstract][Full Text] [Related]
14. Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.
Li X; Xie Y; Hu Y; Lu R; Li Q; Xiong B; Tao H; Chen S
Quant Imaging Med Surg; 2022 Oct; 12(10):4823-4836. PubMed ID: 36185052
[TBL] [Abstract][Full Text] [Related]
15. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
20. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
